We Can Medicines Co (ROCO:6929) ROE % Adjusted to Book Value: -7.09% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6929 We Can Medicines Co Ltd ROCO:6929
46 GF Score
Price NT$22.30
GF Value NT$40.73
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is We Can Medicines Co ROE % Adjusted to Book Value?

We Can Medicines Co ROCO:6929 -0.45% 46 ROE % Adjusted to Book Value is -7.09% as of Dec. 2025. GuruFocus rates ROCO:6929 with a GF Score™ of 46/100 and a GF Value™ of NT$40.73 (Possible Value Trap). The stock has 4 warning signs investors should review.

We Can Medicines Co's ROE % for the quarter that ended in Dec. 2025 was -10.50%. We Can Medicines Co's PB Ratio for the quarter that ended in Dec. 2025 was 1.48. We Can Medicines Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -7.09%.

We Can Medicines Co ROE % Adjusted to Book Value Related Terms

We Can Medicines Co ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for We Can Medicines Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

We Can Medicines Co ROE % Adjusted to Book Value Chart

We Can Medicines Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 0.00 0.35 -3.15 -4.57

We Can Medicines Co Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.71 -2.81 -1.73 -7.66 -7.09

ROCO:6929 vs KHC, GIS: ROE % Adjusted to Book Value Comparison

For the Packaged Foods subindustry, We Can Medicines Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

We Can Medicines Co ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where We Can Medicines Co's ROE % Adjusted to Book Value falls into.


ROCO:6929
46GF Score
We Can Medicines Co Ltd ROCO:6929
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

We Can Medicines Co ROE % Adjusted to Book Value Calculation

We Can Medicines Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-6.76% / 1.48
=-4.57%

We Can Medicines Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-10.50% / 1.48
=-7.09%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -7.09% mean?
We Can Medicines Co (ROCO:6929) has a ROE % Adjusted to Book Value of -7.09% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on We Can Medicines Co and its competitors.
Is We Can Medicines Co's ROE % Adjusted to Book Value too high?
We Can Medicines Co's current ROE % Adjusted to Book Value is -7.09%. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's ROE % Adjusted to Book Value compare to KHC and GIS?
We Can Medicines Co's ROE % Adjusted to Book Value of -7.09% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on We Can Medicines Co and its competitors. We Can Medicines Co's current ROE % Adjusted to Book Value is -7.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$22.30 — trading 45.2% below its estimated fair value. The current ROE % Adjusted to Book Value is -7.09%. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current ROE % Adjusted to Book Value is -7.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?

Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued. The current stock price of NT$22.30 is trading 45.2% below its estimated GF Value™ of NT$40.73. GuruFocus considers We Can Medicines Co to be Possible Value Trap.

Key valuation signals for ROCO:6929:

  • ROE % Adjusted to Book Value: -7.09%
  • GF Value™: NT$40.73 vs. price of NT$22.30 (45.2% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

We Can Medicines Co Business Description

Address Section 4, Taiwan Avenue, 20th Floor-1, No. 925, Xitun District, Taichung, TWN
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score

Get the complete analysis for ROCO:6929

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.30
Price
NT$40.73
GF Value